Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
Compugen Announces Appointment of Alberto Sessa as Chief Financial Officer
Compugen Ltd. ( Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced […]
Cue Health Appoints David Tsay, MD, PhD, as Chief Medical Officer
Cue Health Inc. (“Cue”) ( Nasdaq: HLTH), a healthcare technology company, today announced that it has appointed David […]
ArisGlobal Accelerates Growth, Announces Executive Evolution
ArisGlobal, the leading provider of life sciences software that automates core drug development functions with […]
Evolent Health Announces Dan McCarthy Appointed as President, Frank J. Williams to Retire From Evolent's Board of Directors in 2023
Evolent Health, Inc. ( NYSE: EVH), announced today that New Century Health CEO Dan McCarthy has been named Evolent […]
H.E.L Group Strengthens Leadership Team to Focus on New Product Development and Enhanced Customer Support
H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimisation, […]
Coave Therapeutics Strengthens Leadership Team with the Appointments of Catherine Mathis as Vice President Regulatory Affairs and Julien Berger as Head of Legal Affairs
Coave Therapeutics (‘Coave’), a clinical-stage biotechnology company focused on developing life-changing gene therapies for CNS […]
Lytix Biopharma Appoints Stephen Worsley as Chief Business Officer
Lytix Biopharma (“Lytix”) (Euronext Growth Oslo: LYTIX), a Norwegian immune-oncology company, today announces the appointment […]
Novo Nordisk to Acquire Forma Therapeutics and Expand Presence in Sickle Cell Disease and Rare Blood Disorders
Novo Nordisk and Forma Therapeutics, Holdings Inc. (Nasdaq: FMTX) today announced that they have entered […]
Novartis Appoints Fiona Marshall, Ph.D., President of the Novartis Institutes for BioMedical Research as Jay Bradner, M.d., Steps Down From the Executive Committee of Novartis
Novartis today announced that James (Jay) E. Bradner, M.D., will step down from the Executive […]
Element Biosciences Welcomes Former ThermoFisher Executive Shelly Peariso to their Growing Commercial Team
Element Biosciences, Inc.— developer of the AVITI™ System, a new and disruptive DNA sequencing platform — […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more